Stem Cell Manufacturing Market by Product (HSCs, MSCs, iPSCs, ESCs, Instruments, Media, Consumables), Application (Research, Target Identification, Therapy (Autologous, Allogeneic), Cell Banks), End User (Pharma, Hospitals) - Global Forecast to 2023
Get in-depth analysis of the COVID-19 impact on the Stem Cell Manufacturing Market
Benchmarking the rapid strategy shifts of the Top 100 companies in the Stem Cell Manufacturing Market
Request For Special Pricing[165 Pages Report] The Global Stem Cell Manufacturing Market is projected to reach USD 14.61 Billion by 2023 from USD 10.19 Billion in 2017, at a CAGR of 6.3% during 20182023.
Objectives of the study are:
- To define, describe, and forecast the stem cell manufacturing market on the basis of product, application, end user, and region
- To provide detailed information regarding the major factors influencing the growth of the stem cell manufacturing market (drivers, restraints, opportunities, and industry-specific challenges)
- To strategically analyze micromarkets with respect to their individual growth trends, prospects, and contributions to the total stem cell manufacturing market
- To analyze the growth opportunities in the market for various stakeholders and provide details of the competitive landscape for market leaders
- To forecast the market in terms of value of individual segments with respect to four main regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW)
- To profile key players and comprehensively analyze their market shares and core competencies2
- To track and analyze strategic developments such as product launches; agreements, partnerships, and collaborations; mergers and acquisitions; and research and development activities in the market
This research study involves the extensive usage of secondary sources, directories, and databases (such as, Bloomberg Business, Factiva, and Dun & Bradstreet), in order to identify and collect information useful for this technical, market-oriented, and financial study of the stem cell manufacturing market. In-depth interviews were conducted with various primary respondents, including subject-matter experts (SMEs), C-level executives of key market players, and industry consultants to obtain and verify qualitative and quantitative information and to assess market prospects.
To know about the assumptions considered for the study, download the pdf brochure
In 2016 Thermo Fisher Scientific (US), Merck Group (Germany), and Becton, Dickinson and Company (US), held the leading position in the global stem cell manufacturing market. In the past three years, these companies adopted new product launches & upgrades; agreements, collaborations & partnerships; mergers & acquisitions; and expansions as their key business strategies to ensure market dominance. Bio-Rad Laboratories, Inc. (US), Miltenyi Biotec GmBH (Germany), Takara Bio Group (Japan), STEMCELL Technologies (Canada), Pharmicell (South Korea), Osiris Therapeutics (US), Anterogen (South Korea), Cellular Dynamics International (US), MEDIPOST (South Korea), Lonza Group (Switzerland), Holostem Terapie Avanzate (Italy), and Pluristem Therapeutics (Israel) were some of the other major players in this market.
Stakeholders
- Stem cell therapy product manufacturing companies
- Stem cell line manufacturing companies
- Healthcare service providers (including hospitals and surgical centers)
- Pharmaceutical product manufacturing companies
- National and regional research boards and organizations
- Research and development (R&D) companies
- Clinical research organizations (CROs)
- Research laboratories and academic institutes
- Market research and consulting firms
- Stem cell associations and organizations
- Stem cell banks and tissue banks
- Government regulatory authorities
- Government payers and private insurance companies
Scope of the Report
This report categorizes the global stem cell manufacturing market into the following segments and subsegments:
Global Stem Cell Manufacturing Market, by Product
- Stem Cell Lines
- Embryonic Stem Cells (ESCs)
- Hemopoietic Stem Cells (HSCs)
- Mesenchymal Stem Cells (MSCs)
- Multipotent Adult Progenitor Stem Cells
- Induced Pluripotent Stem Cells (iPSCs)
- Neural Stem Cells (NSCs)
- Instruments
- Bioreactors & Incubators
- Cell Sorters
- Other Instruments
- Culture Media
- Consumables
Global Stem cell Manufacturing Market, by Application
- Research Applications
- Drug Discovery & Development
- Life Science Research
- Clinical Applications
- Autologous Stem Cells
- Allogeneic Stem Cells
- Cell and Tissue Banking Applications
Global Stem Cell Manufacturing Market, by End User
- Hospitals and Surgical Centers
- Pharmaceutical and Biotech Companies
- Cell Banks and Tissue Banks
- Academic Institutes, Research Laboratories, and CROs
- Other End Users
Global Stem Cell Manufacturing Market, by Region
- North America
- US
- Europe
- Asia Pacific
- Rest of the World (RoW)
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the companys specific needs. The following customization options are available for the report:
Product Portfolio
- Product Portfolio matrix, which gives a detailed comparison of the product portfolios of the top five companies profiled in the report
Geographic Analysis
- Further breakdown of the European stem cell manufacturing market into Germany, France, the UK, and Rest of Europe (RoE)
- Further breakdown of the Asia Pacific stem cell manufacturing market into Japan, China, India, and Rest of Asia Pacific (RoAPAC)
The global stem cell manufacturing market is projected to reach USD 14.61 Billion by 2023 from USD 10.75 Billion in 2018, at a CAGR of 6.3%. Factors such as growing public-private investments and funding in stem cell-based research, rising public awareness regarding about the therapeutic potency of stem cell products, development of advanced genomic analysis techniques for quality control during stem cell manufacturing, technological advancements in stem cell manufacturing and preservation, and evolving regulatory frameworks for stem cell therapeutics in the US and Europe are driving the growth of the market.
This report broadly segments the stem cell manufacturing market into product, application, end user, and region. On the basis of product, the market is categorized into culture media, consumables, instruments, and stem cell lines. In 2017, the culture media segment accounted for the largest share of the market. The large market share of this segment is attributed the rising stem cell research and increasing demand for stem cell therapies.
Based on application, the market is categorized into three segments, namely, research, clinical, and cell and tissue banking applications. In 2017, cell and tissue banking applications accounted for the largest share of the market. The dominant share of this segment is credited to the increasing public demand for cord blood Stem Cell Banking and rising awareness regarding the prospective advantages of stem cell preservation.
On the basis of end user, the market is segmented into hospitals and surgical centers; pharmaceutical and biotech companies; cell banks and tissue banks; academic institutes, research laboratories, and CROs; and other end users. In 2017, the pharmaceutical and biotech companies accounted for the largest share of the market. The dominant share of this segment is credited to the rising public-private investments for stem cell-based research, ongoing patent expiry of branded drugs, and increasing patient preference for precision & regenerative medicines.
This report covers the market across four major geographies, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). Of the four geographic regions studied in the report, North America accounted for the largest share of the market in 2017. The high intensity of stem cell research in the region, rising public-private funding and grants to support the clinical evaluation of stem cells for various applications, robust research infrastructure, and rising public awareness on the therapeutic potency of stem cells are driving the growth of the stem cell manufacturing market in North America. However, the Asia Pacific market is projected to register the highest CAGR during the forecast period. The high growth rate in this region can be attributed to the presence/implementation of supportive regulatory frameworks for stem cell research and manufacturing, ongoing expansion & modernization of healthcare infrastructure across emerging Asian countries, and increasing public-private initiatives to encourage public awareness about stem cell-based treatment.
Factor such as significant operational costs associated with stem cell manufacturing & banking is expected to restrain the growth of the market during the forecast period.
The major players in the Stem Cell Manufacturing Market are Thermo Fisher Scientific (US), Merck Group (Germany), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Miltenyi Biotec (Germany), Takara Bio Group (Japan), STEMCELL Technologies (Canada), Pharmicell (South Korea), Osiris Therapeutics (US), Anterogen (South Korea), Cellular Dynamics International (US), MEDIPOST (South Korea), Lonza Group (Switzerland), Holostem Terapie Avanzate (Italy), and Pluristem Therapeutics (Israel), among others.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Table of Contents
1 Introduction (Page No. - 13)
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Markets Covered
1.2.2 Geographic Scope
1.2.3 Years Considered for the Study
1.3 Currency Used
1.4 Market Stakeholders
2 Research Methodology (Page No. - 17)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Secondary Sources
2.1.2 Primary Data
2.1.2.1 Breakdown of Primaries
2.1.2.2 Key Data From Primary Sources
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
2.5 Research Limitations
3 Executive Summary (Page No. - 26)
4 Premium Insights (Page No. - 30)
4.1 Stem Cell Manufacturing: Market Overview (2018)
4.2 Global Stem Cell Manufacturing Market, By Product, 2018
4.3 Stem Cell Manufacturing Market, By Application and Region (2018)
4.4 Stem Cell Manufacturing Market, By End User (2018 vs 2023)
4.5 Geographic Snapshot: Stem Cell Manufacturing Market (2017)
5 Market Overview (Page No. - 34)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Market Drivers
5.2.1.1 Growing Public-Private Investments and Funding in Stem Cell-Based Research
5.2.1.2 Growing Public Awareness About the Therapeutic Potency of Stem Cell Products
5.2.1.3 Development of Advanced Genomic Analysis Techniques for Quality Control During Stem Cell Manufacturing
5.2.1.4 Technological Advancements in Stem Cell Manufacturing and Preservation
5.2.1.5 Evolving Regulatory Frameworks for Stem Cell Therapeutics in the US and Europe
5.2.2 Market Restraints
5.2.2.1 Significant Operational Costs Associated With Stem Cell Manufacturing and Banking
5.2.3 Market Opportunities
5.2.3.1 Increased Market Focus on Embryonic Stem Cells and Induced Pluripotent Stem Cells
5.2.3.2 Supportive Government Regulations Across Developing Countries
5.2.4 Market Challenges
5.2.4.1 Technical Limitations Associated With Manufacturing Scale-Up
5.2.4.2 Socio-Ethical Concerns Related to the Use of Allogenic and Human Embryonic Stem Cells
5.2.5 Research Pipeline Analysis: Stem Cell-Based Products/Therapies
6 Stem Cell Manufacturing Market, By Product (Page No. - 46)
6.1 Introduction
6.2 Culture Media
6.3 Consumables
6.4 Instruments
6.4.1 Bioreactors and Incubators
6.4.2 Cell Sorters
6.4.3 Other Instruments
6.5 Stem Cell Lines
6.5.1 HematopOIEtic Stem Cells
6.5.2 Mesenchymal Stem Cells
6.5.3 Induced Pluripotent Stem Cells
6.5.4 Embryonic Stem Cells
6.5.5 Neural Stem Cells
6.5.6 Multipotent Adult Progenitor Stem Cells
7 Stem Cell Manufacturing Market, By Application (Page No. - 60)
7.1 Introduction
7.2 Research Applications
7.2.1 Drug Discovery and Development
7.2.2 Life Science Research
7.3 Clinical Applications
7.3.1 Allogenic Stem Cell Therapy
7.3.2 Autologous Stem Cell Therapy
7.4 Cell and Tissue Banking Applications
8 Stem Cell Manufacturing Market, By End User (Page No. - 70)
8.1 Introduction
8.2 Pharmaceutical and Biotechnology Companies
8.3 Hospitals and Surgical Centers
8.4 Academic Institutes, Research Laboratories, and Contract Research Organizations
8.5 Cell Banks and Tissue Banks
8.6 Other End Users
9 Stem Cell Manufacturing Market, By Region (Page No. - 77)
9.1 Introduction
9.2 North America
9.2.1 US
9.3 Europe
9.4 Asia Pacific
9.5 Rest of the World
10 Competitive Landscape (Page No. - 100)
10.1 Overview
10.2 Market Ranking (2016)
10.3 Competitive Scenario
10.3.1 Product Launches, Upgrades, and Approvals
10.3.2 Agreements, Partnerships, and Collaborations
10.3.3 Mergers and Acquisitions
10.3.4 Expansions
11 Company Profiles (Page No. - 105)
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
11.1 Anterogen
11.2 Becton, Dickinson and Company (BD)
11.3 Bio-Rad Laboratories
11.4 Cellular Dynamics International (A Subsidiary of Fujifilm Holdings Corporation)
11.5 Holostem Terapie Avanzate
11.6 Lonza Group
11.7 MEDIPOST
11.8 Merck Group
11.9 Miltenyi Biotec
11.10 Osiris Therapeutics
11.11 Pharmicell
11.12 Pluristem Therapeutics
11.13 STEMCELL Technologies
11.14 Takara Bio Group
11.15 Thermo Fisher Scientific
*Details on Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View Might Not Be Captured in Case of Unlisted Companies.
12 Appendix (Page No. - 156)
12.1 Discussion Guide
12.2 Knowledge Store: Marketsandmarkets Subscription Portal
12.3 Introducing RT : Real-Time Market Intelligence
12.4 Available Customizations
12.5 Related Reports
12.6 Author Details
List of Tables (69 Tables)
Table 1 Key Genome-Based Cell Analysis Products Launched During 20142017
Table 2 Stem Cell Manufacturing Market, By Product, 2016-2023 (USD Million)
Table 3 Stem Cell Manufacturing Market for Culture Media, By Region, 2016-2023 (USD Million)
Table 4 Stem Cell Manufacturing Market for Consumables, By Region, 2016-2023 (USD Million)
Table 5 Stem Cell Manufacturing Market for Instruments, By Type, 2016-2023 (USD Million)
Table 6 Stem Cell Manufacturing Market for Instruments, By Region, 2016-2023 (USD Million)
Table 7 Stem Cell Manufacturing Market for Bioreactors & Incubators, By Region, 2016-2023 (USD Million)
Table 8 Stem Cell Manufacturing Market for Cell Sorters, By Region, 2016-2023 (USD Million)
Table 9 Stem Cell Manufacturing Market for Other Instruments, By Region, 2016-2023 (USD Million)
Table 10 Stem Cell Manufacturing Market for Stem Cell Lines, By Type, 2016-2023 (USD Million)
Table 11 Stem Cell Manufacturing Market for Stem Cell Lines, By Region, 2016-2023 (USD Million)
Table 12 Hematopoietic Stem Cells Market, By Region, 2016-2023 (USD Million)
Table 13 Mesenchymal Stem Cells Market, By Region, 2016-2023 (USD Million)
Table 14 Key Expansion and Differentiation Technologies to Extract Human-Induced Pluripotent Stem Cell Lines
Table 15 Induced Pluripotent Stem Cells Market, By Region, 2016-2023 (USD Million)
Table 16 Embryonic Stem Cells Market, By Region, 2016-2023 (USD Million)
Table 17 Neural Stem Cells Market, By Region, 2016-2023 (USD Million)
Table 18 Multipotent Adult Progenitor Stem Cells Market, By Region, 2016-2023 (USD Million)
Table 19 Stem Cell Manufacturing Market, By Application, 20162023 (USD Million)
Table 20 Stem Cell Manufacturing Market for Research Applications, By Type, 20162023 (USD Million)
Table 21 Stem Cell Manufacturing Market for Research Applications, By Region, 20162023 (USD Million)
Table 22 Stem Cell Manufacturing Market for Drug Discovery and Development, By Region, 20162023 (USD Million)
Table 23 Stem Cell Manufacturing Market for Life Science Research, By Region, 20162023 (USD Million)
Table 24 Stem Cell Manufacturing Market for Clinical Applications, By Type, 20162023 (USD Million)
Table 25 Stem Cell Manufacturing Market for Clinical Applications, By Region, 20162023 (USD Million)
Table 26 Stem Cell Manufacturing Market for Allogenic Stem Cell Therapy, By Region, 20162023 (USD Million)
Table 27 Stem Cell Manufacturing Market for Autologous Stem Cell Therapy, By Region, 20162023 (USD Million)
Table 28 Stem Cell Manufacturing Market for Cell & Tissue Banking Applications, By Region, 20162023 (USD Million)
Table 29 Stem Cell Manufacturing Market, By End User, 20162023 (USD Million)
Table 30 Stem Cell Manufacturing Market for Pharmaceutical and Biotechnology Companies, By Region, 20162023 (USD Million)
Table 31 Stem Cell Manufacturing Market for Hospitals and Surgical Centers, By Region, 20162023 (USD Million)
Table 32 Stem Cell Manufacturing Market for Academic Institutes, Research Laboratories, and Contract Research Organizations, By Region, 20162023 (USD Million)
Table 33 Stem Cell Manufacturing Market for Cell Banks and Tissue Banks, By Region, 20162023 (USD Million)
Table 34 Stem Cell Manufacturing Market for Other End Users, By Region, 20162023 (USD Million)
Table 35 Stem Cell Manufacturing Market, By Region, 20162023 (USD Million)
Table 36 North America: Stem Cell Manufacturing Market, By Product, 20162023 (USD Million)
Table 37 North America: Stem Cell Manufacturing Market for Stem Cell Lines, By Type, 20162023 (USD Million)
Table 38 North America: Stem Cell Manufacturing Market for Instruments, By Type, 20162023 (USD Million)
Table 39 North America: Stem Cell Manufacturing Market, By Application, 20162023 (USD Million)
Table 40 North America: Stem Cell Manufacturing Market for Research Applications, By Type, 20162023 (USD Million)
Table 41 North America: Stem Cell Manufacturing Market for Clinical Applications, By Type, 20162023 (USD Million)
Table 42 North America: Stem Cell Manufacturing Market, By End User, 20162023 (USD Million)
Table 43 US: Stem Cell Manufacturing Market, By Product, 20162023 (USD Million)
Table 44 US: Stem Cell Manufacturing Market for Stem Cell Lines, By Type, 20162023 (USD Million)
Table 45 Europe: Stem Cell Manufacturing Market, By Product, 20162023 (USD Million)
Table 46 Europe: Stem Cell Manufacturing Market for Stem Cell Lines, By Type, 20162023 (USD Million)
Table 47 Europe: Stem Cell Manufacturing Market for Instruments, By Type, 20162023 (USD Million)
Table 48 Europe: Stem Cell Manufacturing Market, By Application, 20162023 (USD Million)
Table 49 Europe: Stem Cell Manufacturing Market for Research Applications, By Type, 20162023 (USD Million)
Table 50 Europe: Stem Cell Manufacturing Market for Clinical Applications, By Type, 20162023 (USD Million)
Table 51 Europe: Stem Cell Manufacturing Market, By End User, 20162023 (USD Million)
Table 52 Asia Pacific: Stem Cell Manufacturing Market, By Product, 20162023 (USD Million)
Table 53 Asia Pacific: Stem Cell Manufacturing Market for Stem Cell Lines, By Type, 20162023 (USD Million)
Table 54 Asia Pacific: Stem Cell Manufacturing Market for Instruments, By Type, 20162023 (USD Million)
Table 55 Asia Pacific: Stem Cell Manufacturing Market, By Application, 20162023 (USD Million)
Table 56 Asia Pacific: Stem Cell Manufacturing Market for Research Applications, By Type, 20162023 (USD Million)
Table 57 Asia Pacific: Stem Cell Manufacturing Market for Clinical Applications, By Type, 20162023 (USD Million)
Table 58 Asia Pacific: Stem Cell Manufacturing Market, By End User, 20162023 (USD Million)
Table 59 RoW: Stem Cell Manufacturing Market, By Product, 20162023 (USD Million)
Table 60 RoW: Stem Cell Manufacturing Market for Stem Cell Lines, By Type, 20162023 (USD Million)
Table 61 RoW: Stem Cell Manufacturing Market for Instruments, By Type, 20162023 (USD Million)
Table 62 RoW: Stem Cell Manufacturing Market, By Application, 20162023 (USD Million)
Table 63 RoW: Stem Cell Manufacturing Market for Research Applications, By Type, 20162023 (USD Million)
Table 64 RoW: Stem Cell Manufacturing Market for Clinical Applications, By Type, 20162023 (USD Million)
Table 65 RoW: Stem Cell Manufacturing Market, By End User, 20162023 (USD Million)
Table 66 Key Product Launches, Upgrades, and Approvals, 20142017
Table 67 Key Agreements, Partnerships, and Collaborations, 20142017
Table 68 Key Mergers and Acquisitions, 20142017
Table 69 Key Expansions, 20142017
List of Figures (33 Figures)
Figure 1 Global Stem Cell Manufacturing Market: Research Methodology Steps
Figure 2 Research Design
Figure 3 Stem Cell Manufacturing Market: Bottom-Up Approach
Figure 4 Stem Cell Manufacturing Market: Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Culture Media Segment to Dominate the Global Stem Cell Manufacturing Market During Forecast Period
Figure 7 Research Applications Segment to Dominate the Stem Cell Manufacturing Market During Forecast Period
Figure 8 Cell and Tissue Banks to Be the Fastest-Growing End-User Segment During 20182023
Figure 9 Asia Pacific to Grow at the Highest Rate in the Forecast Period
Figure 10 Rising Public-Private Investments and Funding for Stem Cell-Based Research to Drive Market Growth
Figure 11 Culture Media Segment to Dominate the Global Stem Cell Manufacturing Market During the Forecast Period
Figure 12 North America to Dominate the Stem Cell Manufacturing Market, By Application, in 2018
Figure 13 Cell Banks and Tissue Banks to Be Fastest-Growing Segment During the Forecast Period
Figure 14 North America to Dominate the Global Stem Cell Manufacturing Market During the Forecast Period
Figure 15 Stem Cell Manufacturing Market: Drivers, Restraints, Opportunities, and Challenges
Figure 16 Stem Cell Lines to Be the Fastest-Growing Segment During 2018-2023
Figure 17 Stem Cell Manufacturing Market, By Application, 2018 vs 2023
Figure 18 Stem Cell Manufacturing Market, By End User, 2018 vs 2023
Figure 19 Geographic Snapshot: Asia Pacific to Be the Fastest-Growing Region in the Stem Cell Manufacturing Market During the Forecast Period
Figure 20 North America: Stem Cell Manufacturing Market Snapshot
Figure 21 Europe: Stem Cell Manufacturing Market Snapshot
Figure 22 Asia Pacific: Stem Cell Manufacturing Market Snapshot
Figure 23 RoW: Stem Cell Manufacturing Market Snapshot
Figure 24 Stem Cell Manufacturing Market Ranking Analysis, By Key Player (2016)
Figure 25 BD: Company Snapshot (2017)
Figure 26 Bio-Rad Laboratories: Company Snapshot (2016)
Figure 27 Fujifilm Holdings Corporation: Company Snapshot (2017)
Figure 28 Lonza Group: Company Snapshot (2016)
Figure 29 MEDIPOST: Company Snapshot (2016)
Figure 30 Merck Group: Company Snapshot (2016)
Figure 31 Pluristem Therapeutics: Company Snapshot (2016)
Figure 32 Takara Bio Group: Company Snapshot (2017)
Figure 33 Thermo Fisher Scientific: Company Snapshot (2016)
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Stem Cell Manufacturing Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Growth opportunities and latent adjacency in Stem Cell Manufacturing Market